Update Status of the PATHWAY Database

ID Pathway map Last update

00010 Glycolysis / Gluconeogenesis 10-3-6

00020 Citrate cycle (TCA cycle) 10-3-1

00030 Pentose phosphate pathway 10-3-1

00040 Pentose and glucuronate interconversions 10-3-1

00051 Fructose and mannose metabolism 10-3-1

00052 Galactose metabolism 10-3-1

00053 Ascorbate and aldarate metabolism 09-8-29

00061 Fatty acid biosynthesis 09-8-29

00062 Fatty acid elongation in mitochondria 10-3-1

00071 Fatty acid metabolism 10-3-6

00072 Synthesis and degradation of ketone bodies 10-3-11

00100 Steroid biosynthesis 10-3-1

00120 Primary bile acid biosynthesis 10-3-4

00121 Secondary bile acid biosynthesis 09-11-17

00130 Ubiquinone and other terpenoid-quinone biosynthesis 09-11-17

00140 Steroid hormone biosynthesis 10-3-1

00190 Oxidative phosphorylation 10-3-1

00195 Photosynthesis 09-8-29

00196 Photosynthesis - antenna proteins 09-8-29

00230 Purine metabolism 10-3-1

00231 Puromycin biosynthesis 09-9-7

00232 Caffeine metabolism 09-10-3

00240 Pyrimidine metabolism 10-3-1

00250 Alanine, aspartate and glutamate metabolism 10-3-1

00253 Tetracycline biosynthesis 09-8-29

00260 Glycine, serine and threonine metabolism 10-3-1

00270 Cysteine and methionine metabolism 10-3-1

00280 Valine, leucine and isoleucine degradation 10-3-1

00281 Geraniol degradation 10-3-1

00290 Valine, leucine and isoleucine biosynthesis 10-3-2

00300 Lysine biosynthesis 09-8-29

00310 Lysine degradation 10-3-2

00311 Penicillin and cephalosporin biosynthesis 09-10-15

00312 beta-Lactam resistance 09-6-18

00330 Arginine and proline metabolism 10-3-2

00331 Clavulanic acid biosynthesis 09-9-24

00340 Histidine metabolism 09-8-29

00350 Tyrosine metabolism 10-3-6

00351 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation 10-3-2

00360 Phenylalanine metabolism 10-3-2

00361 gamma-Hexachlorocyclohexane degradation 09-8-29

00362 Benzoate degradation via hydroxylation 09-8-29

00363 Bisphenol A degradation 09-8-29

00364 Fluorobenzoate degradation 09-8-29

00380 Tryptophan metabolism 10-3-2

00400 Phenylalanine, tyrosine and tryptophan biosynthesis 10-3-6

00401 Novobiocin biosynthesis 09-10-2

00402 Benzoxazinoid biosynthesis 10-1-7

00410 beta-Alanine metabolism 10-3-2

00430 Taurine and hypotaurine metabolism 09-8-29

00440 Phosphonate and phosphinate metabolism 09-11-10

00450 Selenoamino acid metabolism 09-12-1

00460 Cyanoamino acid metabolism 10-3-2

00471 D-Glutamine and D-glutamate metabolism 09-8-29

00472 D-Arginine and D-ornithine metabolism 09-10-16

00473 D-Alanine metabolism 09-8-28

00480 Glutathione metabolism 10-3-2

00500 Starch and sucrose metabolism 10-3-2

00510 N-Glycan biosynthesis 10-3-2

00511 Other glycan degradation 09-7-1

00512 O-Glycan biosynthesis 10-3-2

00513 High-mannose type N-glycan biosynthesis 09-8-29

00514 O-Mannosyl glycan biosynthesis 10-3-2

00520 Amino sugar and nucleotide sugar metabolism 10-3-2

00521 Streptomycin biosynthesis 10-3-2

00522 Biosynthesis of 12-, 14- and 16-membered macrolides 09-10-2

00523 Polyketide sugar unit biosynthesis 10-3-2

00531 Glycosaminoglycan degradation 09-8-29

00532 Glycosaminoglycan biosynthesis - chondroitin sulfate 10-3-9

00533 Glycosaminoglycan biosynthesis - keratan sulfate 10-3-9

00534 Glycosaminoglycan biosynthesis - heparan sulfate 10-3-9

00540 Lipopolysaccharide biosynthesis 09-11-17

00550 Peptidoglycan biosynthesis 09-8-29

00561 Glycerolipid metabolism 10-3-2

00562 Inositol phosphate metabolism 10-3-2

00563 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis 10-3-2

00564 Glycerophospholipid metabolism 10-3-2

00565 Ether lipid metabolism 09-8-29

00590 Arachidonic acid metabolism 10-3-2

00591 Linoleic acid metabolism 09-10-30

00592 alpha-Linolenic acid metabolism 10-3-2

00600 Sphingolipid metabolism 09-12-19

00601 Glycosphingolipid biosynthesis - lacto and neolacto series 09-8-29

00603 Glycosphingolipid biosynthesis - globo series 09-9-3

00604 Glycosphingolipid biosynthesis - ganglio series 09-9-3

00620 Pyruvate metabolism 10-3-2

00621 Biphenyl degradation 09-8-29

00622 Toluene and xylene degradation 09-8-29

00623 2,4-Dichlorobenzoate degradation 10-3-2

00624 1- and 2-Methylnaphthalene degradation 10-3-6

00625 Tetrachloroethene degradation 10-3-2

00626 Naphthalene and anthracene degradation 09-11-17

00627 1,4-Dichlorobenzene degradation 09-9-2

00628 Fluorene degradation 09-9-2

00629 Carbazole degradation 09-9-2

00630 Glyoxylate and dicarboxylate metabolism 10-3-2

00631 1,2-Dichloroethane degradation 10-3-2

00632 Benzoate degradation via CoA ligation 10-3-2

00633 Trinitrotoluene degradation 10-3-2

00640 Propanoate metabolism 10-3-2

00641 3-Chloroacrylic acid degradation 10-3-6

00642 Ethylbenzene degradation 09-9-2

00643 Styrene degradation 09-10-8

00650 Butanoate metabolism 10-3-2

00660 C5-Branched dibasic acid metabolism 10-3-2

00670 One carbon pool by folate 10-3-2

00680 Methane metabolism 10-3-2

00710 Carbon fixation in photosynthetic organisms 09-9-2

00720 Reductive carboxylate cycle (CO2 fixation) 09-9-2

00730 Thiamine metabolism 09-9-2

00740 Riboflavin metabolism 09-11-18

00750 Vitamin B6 metabolism 10-1-9

00760 Nicotinate and nicotinamide metabolism 10-3-2

00770 Pantothenate and CoA biosynthesis 09-12-3

00780 Biotin metabolism 09-9-2

00785 Lipoic acid metabolism 09-10-2

00790 Folate biosynthesis 10-3-2

00791 Atrazine degradation 09-9-2

00830 Retinol metabolism 10-3-6

00860 Porphyrin and chlorophyll metabolism 09-11-18

00900 Terpenoid backbone biosynthesis 10-3-2

00901 Indole alkaloid biosynthesis 09-10-10

00902 Monoterpenoid biosynthesis 10-3-2

00903 Limonene and pinene degradation 10-3-2

00904 Diterpenoid biosynthesis 10-3-2

00905 Brassinosteroid biosynthesis 09-9-10

00906 Carotenoid biosynthesis 10-1-6

00908 Zeatin biosynthesis 10-3-9

00909 Sesquiterpenoid biosynthesis 09-9-3

00910 Nitrogen metabolism 10-3-2

00920 Sulfur metabolism 09-12-1

00930 Caprolactam degradation 10-3-2

00940 Phenylpropanoid biosynthesis 10-3-4

00941 Flavonoid biosynthesis 10-1-7

00942 Anthocyanin biosynthesis 09-11-5

00943 Isoflavonoid biosynthesis 10-3-2

00944 Flavone and flavonol biosynthesis 10-3-2

00945 Stilbenoid, diarylheptanoid and gingerol biosynthesis 10-1-7

00950 Isoquinoline alkaloid biosynthesis 10-3-2

00960 Tropane, piperidine and pyridine alkaloid biosynthesis 10-3-2

00965 Betalain biosynthesis 09-9-3

00966 Glucosinolate biosynthesis 10-3-2

00970 Aminoacyl-tRNA biosynthesis 09-9-3

00980 Metabolism of xenobiotics by cytochrome P450 10-3-6

00981 Insect hormone biosynthesis 09-9-3

00982 Drug metabolism - cytochrome P450 10-3-6

00983 Drug metabolism - other enzymes 10-3-2

01010 Overview of biosynthetic pathways 09-7-29

01040 Biosynthesis of unsaturated fatty acids 10-3-2

01051 Biosynthesis of ansamycins 09-9-3

01052 Type I polyketide structures 09-6-19

01053 Biosynthesis of siderophore group nonribosomal peptides 09-9-3

01054 Nonribosomal peptide structures 10-3-4

01055 Biosynthesis of vancomycin group antibiotics 10-3-2

01056 Biosynthesis of type II polyketide backbone 09-10-2

01057 Biosynthesis of type II polyketide products 09-9-3

01058 Acridone alkaloid biosynthesis 09-9-11

01060 Biosynthesis of plant secondary metabolites 09-11-18

01061 Biosynthesis of phenylpropanoids 10-3-2

01062 Biosynthesis of terpenoids and steroids 10-3-2

01063 Biosynthesis of alkaloids derived from shikimate pathway 10-3-2

01064 Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid 09-8-26

01065 Biosynthesis of alkaloids derived from histidine and purine 10-3-2

01066 Biosynthesis of alkaloids derived from terpenoid and polyketide 10-3-2

01070 Biosynthesis of plant hormones 10-3-2

01100 Metabolic pathways 10-3-6

02010 ABC transporters 10-3-2

02020 Two-component system 10-3-4

02030 Bacterial chemotaxis 09-7-4

02040 Flagellar assembly 09-6-19

02060 Phosphotransferase system (PTS) 10-3-3

03010 Ribosome 10-3-4

03018 RNA degradation 10-3-2

03020 RNA polymerase 10-3-2

03022 Basal transcription factors 09-6-19

03030 DNA replication 09-6-19

03040 Spliceosome 10-3-2

03050 Proteasome 10-3-2

03060 Protein export 10-3-2

03070 Bacterial secretion system 10-3-2

03320 PPAR signaling pathway 10-3-2

03410 Base excision repair 09-10-23

03420 Nucleotide excision repair 09-9-12

03430 Mismatch repair 09-9-12

03440 Homologous recombination 09-9-12

03450 Non-homologous end-joining 09-9-12

04010 MAPK signaling pathway 10-3-2

04011 MAPK signaling pathway - yeast 10-3-4

04012 ErbB signaling pathway 09-6-19

04013 MAPK signaling pathway - fly 09-7-1

04020 Calcium signaling pathway 10-3-2

04060 Cytokine-cytokine receptor interaction 10-3-2

04062 Chemokine signaling pathway 10-3-11

04070 Phosphatidylinositol signaling system 09-6-19

04080 Neuroactive ligand-receptor interaction 10-3-2

04110 Cell cycle 10-3-2

04111 Cell cycle - yeast 10-3-2

04113 Meiosis - yeast 10-3-2

04114 Oocyte meiosis 10-3-2

04115 p53 signaling pathway 10-3-2

04120 Ubiquitin mediated proteolysis 10-3-3

04130 SNARE interactions in vesicular transport 10-3-4

04140 Regulation of autophagy 10-3-2

04142 Lysosome 10-3-2

04144 Endocytosis 10-3-2

04146 Peroxisome 10-3-2

04150 mTOR signaling pathway 09-6-19

04210 Apoptosis 10-3-2

04260 Cardiac muscle contraction 10-3-2

04270 Vascular smooth muscle contraction 09-10-17

04310 Wnt signaling pathway 10-3-4

04320 Dorso-ventral axis formation 10-3-2

04330 Notch signaling pathway 10-3-2

04340 Hedgehog signaling pathway 09-6-19

04350 TGF-beta signaling pathway 10-3-3

04360 Axon guidance 10-3-2

04370 VEGF signaling pathway 10-3-2

04510 Focal adhesion 10-3-2

04512 ECM-receptor interaction 10-3-4

04514 Cell adhesion molecules (CAMs) 10-3-2

04520 Adherens junction 10-3-4

04530 Tight junction 10-3-2

04540 Gap junction 09-6-19

04610 Complement and coagulation cascades 10-3-2

04612 Antigen processing and presentation 10-3-2

04614 Renin-angiotensin system 10-3-2

04620 Toll-like receptor signaling pathway 10-3-2

04621 NOD-like receptor signaling pathway 10-3-2

04622 RIG-I-like receptor signaling pathway 10-3-2

04623 Cytosolic DNA-sensing pathway 10-3-2

04626 Plant-pathogen interaction 10-3-2

04630 Jak-STAT signaling pathway 10-3-2

04640 Hematopoietic cell lineage 10-3-2

04650 Natural killer cell mediated cytotoxicity 10-3-2

04660 T cell receptor signaling pathway 09-11-18

04662 B cell receptor signaling pathway 10-3-2

04664 Fc epsilon RI signaling pathway 10-3-2

04666 Fc gamma R-mediated phagocytosis 10-3-2

04670 Leukocyte transendothelial migration 10-3-2

04672 Intestinal immune network for IgA production 10-3-2

04710 Circadian rhythm - mammal 09-6-19

04711 Circadian rhythm - fly 09-6-19

04712 Circadian rhythm - plant 09-6-19

04720 Long-term potentiation 09-6-19

04722 Neurotrophin signaling pathway 09-7-18

04730 Long-term depression 10-1-9

04740 Olfactory transduction 09-6-19

04742 Taste transduction 10-3-4

04810 Regulation of actin cytoskeleton 10-3-2

04910 Insulin signaling pathway 10-3-3

04912 GnRH signaling pathway 09-6-19

04914 Progesterone-mediated oocyte maturation 10-3-3

04916 Melanogenesis 09-6-19

04920 Adipocytokine signaling pathway 10-3-2

04930 Type II diabetes mellitus 09-7-3

04940 Type I diabetes mellitus 10-3-2

04950 Maturity onset diabetes of the young 09-7-3

04960 Aldosterone-regulated sodium reabsorption 10-3-2

04962 Vasopressin-regulated water reabsorption 10-3-9

05010 Alzheimer's disease 10-3-2

05012 Parkinson's disease 10-3-2

05014 Amyotrophic lateral sclerosis (ALS) 10-3-2

05016 Huntington's disease 10-3-2

05020 Prion diseases 10-3-2

05110 Vibrio cholerae infection 09-6-19

05111 Vibrio cholerae pathogenic cycle 09-6-19

05120 Epithelial cell signaling in Helicobacter pylori infection 10-3-2

05130 Pathogenic Escherichia coli infection 09-11-17

05200 Pathways in cancer 10-3-2

05210 Colorectal cancer 10-3-2

05211 Renal cell carcinoma 10-3-3

05212 Pancreatic cancer 10-3-2

05213 Endometrial cancer 10-3-2

05214 Glioma 10-3-3

05215 Prostate cancer 10-3-2

05216 Thyroid cancer 10-3-3

05217 Basal cell carcinoma 10-3-3

05218 Melanoma 10-3-3

05219 Bladder cancer 10-3-3

05220 Chronic myeloid leukemia 10-3-3

05221 Acute myeloid leukemia 10-3-3

05222 Small cell lung cancer 10-3-2

05223 Non-small cell lung cancer 10-3-2

05310 Asthma 10-3-2

05320 Autoimmune thyroid disease 10-3-2

05322 Systemic lupus erythematosus 10-3-2

05330 Allograft rejection 10-3-2

05332 Graft-versus-host disease 10-3-2

05340 Primary immunodeficiency 10-3-2

05410 Hypertrophic cardiomyopathy (HCM) 10-3-2

05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) 10-3-2

05414 Dilated cardiomyopathy 10-3-2

05416 Viral myocarditis 10-3-2

07011 Penicillins 09-12-16

07012 Cephalosporins - parenteral agents 09-6-19

07013 Cephalosporins - oral agents 10-3-3

07014 Quinolones 09-6-19

07015 Local analgesics 09-8-26

07016 Sulfonamide derivatives - sulfa drugs 10-3-3

07017 Sulfonamide derivatives - diuretics 10-3-3

07018 Sulfonamide derivatives - hypoglycemic agents 09-6-19

07019 Tetracyclines 09-8-28

07020 Macrolides and ketolides 09-6-19

07021 Aminoglycosides 10-3-3

07023 Rifamycins 09-8-12

07024 Statins 09-6-19

07025 Quinolines 09-9-4

07026 Azoles 09-6-19

07027 Antidepressants 09-8-29

07028 Antipsychotics 09-6-19

07029 Phenothiazines 09-9-8

07030 Anxiolytics 09-6-19

07031 Butyrophenones 09-6-19

07032 Hypnotics 09-6-19

07033 Anticonvulsants 09-6-19

07034 Eicosanoids 10-1-7

07035 Prostaglandins 09-6-19

07036 Calcium channel-blocking drugs 09-6-19

07037 Antiarrhythmic drugs 09-6-19

07038 Antacids 09-9-17

07039 Opioid analgesics 09-6-19

07040 Antineoplastics - alkylating agents 09-6-19

07041 Antineoplastics - antimetabolic agents 09-7-1

07042 Antineoplastics - agents from natural products 09-12-10

07043 Antineoplastics - hormones 09-6-19

07044 Antivirals 10-3-3

07045 Antineoplastics - protein kinases inhibitors 09-9-19

07046 Immunosuppressive agents 10-3-3

07047 Osteoporosis drugs 10-3-3

07110 Benzoic acid family 09-6-19

07111 2-Aminothiazole family 09-10-10

07112 1,2-Diphenyl substitution family 09-6-19

07113 Furan family 09-6-19

07114 Naphthalene family 09-6-19

07115 Sulfonamide family 09-9-20

07116 Butyrophenone family 09-6-19

07117 Benzodiazepine family 09-6-19

07211 Serotonin receptor agonists/antagonists 10-3-3

07212 Histamine receptor antagonists 09-9-16

07213 Dopamine receptor agonists/antagonists 09-9-19

07214 beta-Adrenergic receptor agonists/antagonists 09-9-8

07215 alpha-Adrenergic receptor agonists/antagonists 09-6-19

07216 Catecholamine transferase inhibitors 09-6-19

07217 Angiotensin antagonists 09-6-19

07218 HIV protease inhibitors 09-11-13

07219 Cyclooxygenase inhibitors 09-11-12

07220 Cholinergic and anticholinergic drugs 09-10-10

07221 Nicotinic cholinergic receptor antagonists 09-6-19

07222 Peroxisome proliferator-activated receptor (PPAR) agonists 09-11-24

07223 Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists 09-12-29

ID	Pathway map	Last update
00010	Glycolysis / Gluconeogenesis	10-3-6
00020	Citrate cycle (TCA cycle)	10-3-1
00030	Pentose phosphate pathway	10-3-1
00040	Pentose and glucuronate interconversions	10-3-1
00051	Fructose and mannose metabolism	10-3-1
00052	Galactose metabolism	10-3-1
00053	Ascorbate and aldarate metabolism	09-8-29
00061	Fatty acid biosynthesis	09-8-29
00062	Fatty acid elongation in mitochondria	10-3-1
00071	Fatty acid metabolism	10-3-6
00072	Synthesis and degradation of ketone bodies	10-3-11
00100	Steroid biosynthesis	10-3-1
00120	Primary bile acid biosynthesis	10-3-4
00121	Secondary bile acid biosynthesis	09-11-17
00130	Ubiquinone and other terpenoid-quinone biosynthesis	09-11-17
00140	Steroid hormone biosynthesis	10-3-1
00190	Oxidative phosphorylation	10-3-1
00195	Photosynthesis	09-8-29
00196	Photosynthesis - antenna proteins	09-8-29
00230	Purine metabolism	10-3-1
00231	Puromycin biosynthesis	09-9-7
00232	Caffeine metabolism	09-10-3
00240	Pyrimidine metabolism	10-3-1
00250	Alanine, aspartate and glutamate metabolism	10-3-1
00253	Tetracycline biosynthesis	09-8-29
00260	Glycine, serine and threonine metabolism	10-3-1
00270	Cysteine and methionine metabolism	10-3-1
00280	Valine, leucine and isoleucine degradation	10-3-1
00281	Geraniol degradation	10-3-1
00290	Valine, leucine and isoleucine biosynthesis	10-3-2
00300	Lysine biosynthesis	09-8-29
00310	Lysine degradation	10-3-2
00311	Penicillin and cephalosporin biosynthesis	09-10-15
00312	beta-Lactam resistance	09-6-18
00330	Arginine and proline metabolism	10-3-2
00331	Clavulanic acid biosynthesis	09-9-24
00340	Histidine metabolism	09-8-29
00350	Tyrosine metabolism	10-3-6
00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	10-3-2
00360	Phenylalanine metabolism	10-3-2
00361	gamma-Hexachlorocyclohexane degradation	09-8-29
00362	Benzoate degradation via hydroxylation	09-8-29
00363	Bisphenol A degradation	09-8-29
00364	Fluorobenzoate degradation	09-8-29
00380	Tryptophan metabolism	10-3-2
00400	Phenylalanine, tyrosine and tryptophan biosynthesis	10-3-6
00401	Novobiocin biosynthesis	09-10-2
00402	Benzoxazinoid biosynthesis	10-1-7
00410	beta-Alanine metabolism	10-3-2
00430	Taurine and hypotaurine metabolism	09-8-29
00440	Phosphonate and phosphinate metabolism	09-11-10
00450	Selenoamino acid metabolism	09-12-1
00460	Cyanoamino acid metabolism	10-3-2
00471	D-Glutamine and D-glutamate metabolism	09-8-29
00472	D-Arginine and D-ornithine metabolism	09-10-16
00473	D-Alanine metabolism	09-8-28
00480	Glutathione metabolism	10-3-2
00500	Starch and sucrose metabolism	10-3-2
00510	N-Glycan biosynthesis	10-3-2
00511	Other glycan degradation	09-7-1
00512	O-Glycan biosynthesis	10-3-2
00513	High-mannose type N-glycan biosynthesis	09-8-29
00514	O-Mannosyl glycan biosynthesis	10-3-2
00520	Amino sugar and nucleotide sugar metabolism	10-3-2
00521	Streptomycin biosynthesis	10-3-2
00522	Biosynthesis of 12-, 14- and 16-membered macrolides	09-10-2
00523	Polyketide sugar unit biosynthesis	10-3-2
00531	Glycosaminoglycan degradation	09-8-29
00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	10-3-9
00533	Glycosaminoglycan biosynthesis - keratan sulfate	10-3-9
00534	Glycosaminoglycan biosynthesis - heparan sulfate	10-3-9
00540	Lipopolysaccharide biosynthesis	09-11-17
00550	Peptidoglycan biosynthesis	09-8-29
00561	Glycerolipid metabolism	10-3-2
00562	Inositol phosphate metabolism	10-3-2
00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	10-3-2
00564	Glycerophospholipid metabolism	10-3-2
00565	Ether lipid metabolism	09-8-29
00590	Arachidonic acid metabolism	10-3-2
00591	Linoleic acid metabolism	09-10-30
00592	alpha-Linolenic acid metabolism	10-3-2
00600	Sphingolipid metabolism	09-12-19
00601	Glycosphingolipid biosynthesis - lacto and neolacto series	09-8-29
00603	Glycosphingolipid biosynthesis - globo series	09-9-3
00604	Glycosphingolipid biosynthesis - ganglio series	09-9-3
00620	Pyruvate metabolism	10-3-2
00621	Biphenyl degradation	09-8-29
00622	Toluene and xylene degradation	09-8-29
00623	2,4-Dichlorobenzoate degradation	10-3-2
00624	1- and 2-Methylnaphthalene degradation	10-3-6
00625	Tetrachloroethene degradation	10-3-2
00626	Naphthalene and anthracene degradation	09-11-17
00627	1,4-Dichlorobenzene degradation	09-9-2
00628	Fluorene degradation	09-9-2
00629	Carbazole degradation	09-9-2
00630	Glyoxylate and dicarboxylate metabolism	10-3-2
00631	1,2-Dichloroethane degradation	10-3-2
00632	Benzoate degradation via CoA ligation	10-3-2
00633	Trinitrotoluene degradation	10-3-2
00640	Propanoate metabolism	10-3-2
00641	3-Chloroacrylic acid degradation	10-3-6
00642	Ethylbenzene degradation	09-9-2
00643	Styrene degradation	09-10-8
00650	Butanoate metabolism	10-3-2
00660	C5-Branched dibasic acid metabolism	10-3-2
00670	One carbon pool by folate	10-3-2
00680	Methane metabolism	10-3-2
00710	Carbon fixation in photosynthetic organisms	09-9-2
00720	Reductive carboxylate cycle (CO2 fixation)	09-9-2
00730	Thiamine metabolism	09-9-2
00740	Riboflavin metabolism	09-11-18
00750	Vitamin B6 metabolism	10-1-9
00760	Nicotinate and nicotinamide metabolism	10-3-2
00770	Pantothenate and CoA biosynthesis	09-12-3
00780	Biotin metabolism	09-9-2
00785	Lipoic acid metabolism	09-10-2
00790	Folate biosynthesis	10-3-2
00791	Atrazine degradation	09-9-2
00830	Retinol metabolism	10-3-6
00860	Porphyrin and chlorophyll metabolism	09-11-18
00900	Terpenoid backbone biosynthesis	10-3-2
00901	Indole alkaloid biosynthesis	09-10-10
00902	Monoterpenoid biosynthesis	10-3-2
00903	Limonene and pinene degradation	10-3-2
00904	Diterpenoid biosynthesis	10-3-2
00905	Brassinosteroid biosynthesis	09-9-10
00906	Carotenoid biosynthesis	10-1-6
00908	Zeatin biosynthesis	10-3-9
00909	Sesquiterpenoid biosynthesis	09-9-3
00910	Nitrogen metabolism	10-3-2
00920	Sulfur metabolism	09-12-1
00930	Caprolactam degradation	10-3-2
00940	Phenylpropanoid biosynthesis	10-3-4
00941	Flavonoid biosynthesis	10-1-7
00942	Anthocyanin biosynthesis	09-11-5
00943	Isoflavonoid biosynthesis	10-3-2
00944	Flavone and flavonol biosynthesis	10-3-2
00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	10-1-7
00950	Isoquinoline alkaloid biosynthesis	10-3-2
00960	Tropane, piperidine and pyridine alkaloid biosynthesis	10-3-2
00965	Betalain biosynthesis	09-9-3
00966	Glucosinolate biosynthesis	10-3-2
00970	Aminoacyl-tRNA biosynthesis	09-9-3
00980	Metabolism of xenobiotics by cytochrome P450	10-3-6
00981	Insect hormone biosynthesis	09-9-3
00982	Drug metabolism - cytochrome P450	10-3-6
00983	Drug metabolism - other enzymes	10-3-2
01010	Overview of biosynthetic pathways	09-7-29
01040	Biosynthesis of unsaturated fatty acids	10-3-2
01051	Biosynthesis of ansamycins	09-9-3
01052	Type I polyketide structures	09-6-19
01053	Biosynthesis of siderophore group nonribosomal peptides	09-9-3
01054	Nonribosomal peptide structures	10-3-4
01055	Biosynthesis of vancomycin group antibiotics	10-3-2
01056	Biosynthesis of type II polyketide backbone	09-10-2
01057	Biosynthesis of type II polyketide products	09-9-3
01058	Acridone alkaloid biosynthesis	09-9-11
01060	Biosynthesis of plant secondary metabolites	09-11-18
01061	Biosynthesis of phenylpropanoids	10-3-2
01062	Biosynthesis of terpenoids and steroids	10-3-2
01063	Biosynthesis of alkaloids derived from shikimate pathway	10-3-2
01064	Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid	09-8-26
01065	Biosynthesis of alkaloids derived from histidine and purine	10-3-2
01066	Biosynthesis of alkaloids derived from terpenoid and polyketide	10-3-2
01070	Biosynthesis of plant hormones	10-3-2
01100	Metabolic pathways	10-3-6
02010	ABC transporters	10-3-2
02020	Two-component system	10-3-4
02030	Bacterial chemotaxis	09-7-4
02040	Flagellar assembly	09-6-19
02060	Phosphotransferase system (PTS)	10-3-3
03010	Ribosome	10-3-4
03018	RNA degradation	10-3-2
03020	RNA polymerase	10-3-2
03022	Basal transcription factors	09-6-19
03030	DNA replication	09-6-19
03040	Spliceosome	10-3-2
03050	Proteasome	10-3-2
03060	Protein export	10-3-2
03070	Bacterial secretion system	10-3-2
03320	PPAR signaling pathway	10-3-2
03410	Base excision repair	09-10-23
03420	Nucleotide excision repair	09-9-12
03430	Mismatch repair	09-9-12
03440	Homologous recombination	09-9-12
03450	Non-homologous end-joining	09-9-12
04010	MAPK signaling pathway	10-3-2
04011	MAPK signaling pathway - yeast	10-3-4
04012	ErbB signaling pathway	09-6-19
04013	MAPK signaling pathway - fly	09-7-1
04020	Calcium signaling pathway	10-3-2
04060	Cytokine-cytokine receptor interaction	10-3-2
04062	Chemokine signaling pathway	10-3-11
04070	Phosphatidylinositol signaling system	09-6-19
04080	Neuroactive ligand-receptor interaction	10-3-2
04110	Cell cycle	10-3-2
04111	Cell cycle - yeast	10-3-2
04113	Meiosis - yeast	10-3-2
04114	Oocyte meiosis	10-3-2
04115	p53 signaling pathway	10-3-2
04120	Ubiquitin mediated proteolysis	10-3-3
04130	SNARE interactions in vesicular transport	10-3-4
04140	Regulation of autophagy	10-3-2
04142	Lysosome	10-3-2
04144	Endocytosis	10-3-2
04146	Peroxisome	10-3-2
04150	mTOR signaling pathway	09-6-19
04210	Apoptosis	10-3-2
04260	Cardiac muscle contraction	10-3-2
04270	Vascular smooth muscle contraction	09-10-17
04310	Wnt signaling pathway	10-3-4
04320	Dorso-ventral axis formation	10-3-2
04330	Notch signaling pathway	10-3-2
04340	Hedgehog signaling pathway	09-6-19
04350	TGF-beta signaling pathway	10-3-3
04360	Axon guidance	10-3-2
04370	VEGF signaling pathway	10-3-2
04510	Focal adhesion	10-3-2
04512	ECM-receptor interaction	10-3-4
04514	Cell adhesion molecules (CAMs)	10-3-2
04520	Adherens junction	10-3-4
04530	Tight junction	10-3-2
04540	Gap junction	09-6-19
04610	Complement and coagulation cascades	10-3-2
04612	Antigen processing and presentation	10-3-2
04614	Renin-angiotensin system	10-3-2
04620	Toll-like receptor signaling pathway	10-3-2
04621	NOD-like receptor signaling pathway	10-3-2
04622	RIG-I-like receptor signaling pathway	10-3-2
04623	Cytosolic DNA-sensing pathway	10-3-2
04626	Plant-pathogen interaction	10-3-2
04630	Jak-STAT signaling pathway	10-3-2
04640	Hematopoietic cell lineage	10-3-2
04650	Natural killer cell mediated cytotoxicity	10-3-2
04660	T cell receptor signaling pathway	09-11-18
04662	B cell receptor signaling pathway	10-3-2
04664	Fc epsilon RI signaling pathway	10-3-2
04666	Fc gamma R-mediated phagocytosis	10-3-2
04670	Leukocyte transendothelial migration	10-3-2
04672	Intestinal immune network for IgA production	10-3-2
04710	Circadian rhythm - mammal	09-6-19
04711	Circadian rhythm - fly	09-6-19
04712	Circadian rhythm - plant	09-6-19
04720	Long-term potentiation	09-6-19
04722	Neurotrophin signaling pathway	09-7-18
04730	Long-term depression	10-1-9
04740	Olfactory transduction	09-6-19
04742	Taste transduction	10-3-4
04810	Regulation of actin cytoskeleton	10-3-2
04910	Insulin signaling pathway	10-3-3
04912	GnRH signaling pathway	09-6-19
04914	Progesterone-mediated oocyte maturation	10-3-3
04916	Melanogenesis	09-6-19
04920	Adipocytokine signaling pathway	10-3-2
04930	Type II diabetes mellitus	09-7-3
04940	Type I diabetes mellitus	10-3-2
04950	Maturity onset diabetes of the young	09-7-3
04960	Aldosterone-regulated sodium reabsorption	10-3-2
04962	Vasopressin-regulated water reabsorption	10-3-9
05010	Alzheimer's disease	10-3-2
05012	Parkinson's disease	10-3-2
05014	Amyotrophic lateral sclerosis (ALS)	10-3-2
05016	Huntington's disease	10-3-2
05020	Prion diseases	10-3-2
05110	Vibrio cholerae infection	09-6-19
05111	Vibrio cholerae pathogenic cycle	09-6-19
05120	Epithelial cell signaling in Helicobacter pylori infection	10-3-2
05130	Pathogenic Escherichia coli infection	09-11-17
05200	Pathways in cancer	10-3-2
05210	Colorectal cancer	10-3-2
05211	Renal cell carcinoma	10-3-3
05212	Pancreatic cancer	10-3-2
05213	Endometrial cancer	10-3-2
05214	Glioma	10-3-3
05215	Prostate cancer	10-3-2
05216	Thyroid cancer	10-3-3
05217	Basal cell carcinoma	10-3-3
05218	Melanoma	10-3-3
05219	Bladder cancer	10-3-3
05220	Chronic myeloid leukemia	10-3-3
05221	Acute myeloid leukemia	10-3-3
05222	Small cell lung cancer	10-3-2
05223	Non-small cell lung cancer	10-3-2
05310	Asthma	10-3-2
05320	Autoimmune thyroid disease	10-3-2
05322	Systemic lupus erythematosus	10-3-2
05330	Allograft rejection	10-3-2
05332	Graft-versus-host disease	10-3-2
05340	Primary immunodeficiency	10-3-2
05410	Hypertrophic cardiomyopathy (HCM)	10-3-2
05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	10-3-2
05414	Dilated cardiomyopathy	10-3-2
05416	Viral myocarditis	10-3-2
07011	Penicillins	09-12-16
07012	Cephalosporins - parenteral agents	09-6-19
07013	Cephalosporins - oral agents	10-3-3
07014	Quinolones	09-6-19
07015	Local analgesics	09-8-26
07016	Sulfonamide derivatives - sulfa drugs	10-3-3
07017	Sulfonamide derivatives - diuretics	10-3-3
07018	Sulfonamide derivatives - hypoglycemic agents	09-6-19
07019	Tetracyclines	09-8-28
07020	Macrolides and ketolides	09-6-19
07021	Aminoglycosides	10-3-3
07023	Rifamycins	09-8-12
07024	Statins	09-6-19
07025	Quinolines	09-9-4
07026	Azoles	09-6-19
07027	Antidepressants	09-8-29
07028	Antipsychotics	09-6-19
07029	Phenothiazines	09-9-8
07030	Anxiolytics	09-6-19
07031	Butyrophenones	09-6-19
07032	Hypnotics	09-6-19
07033	Anticonvulsants	09-6-19
07034	Eicosanoids	10-1-7
07035	Prostaglandins	09-6-19
07036	Calcium channel-blocking drugs	09-6-19
07037	Antiarrhythmic drugs	09-6-19
07038	Antacids	09-9-17
07039	Opioid analgesics	09-6-19
07040	Antineoplastics - alkylating agents	09-6-19
07041	Antineoplastics - antimetabolic agents	09-7-1
07042	Antineoplastics - agents from natural products	09-12-10
07043	Antineoplastics - hormones	09-6-19
07044	Antivirals	10-3-3
07045	Antineoplastics - protein kinases inhibitors	09-9-19
07046	Immunosuppressive agents	10-3-3
07047	Osteoporosis drugs	10-3-3
07110	Benzoic acid family	09-6-19
07111	2-Aminothiazole family	09-10-10
07112	1,2-Diphenyl substitution family	09-6-19
07113	Furan family	09-6-19
07114	Naphthalene family	09-6-19
07115	Sulfonamide family	09-9-20
07116	Butyrophenone family	09-6-19
07117	Benzodiazepine family	09-6-19
07211	Serotonin receptor agonists/antagonists	10-3-3
07212	Histamine receptor antagonists	09-9-16
07213	Dopamine receptor agonists/antagonists	09-9-19
07214	beta-Adrenergic receptor agonists/antagonists	09-9-8
07215	alpha-Adrenergic receptor agonists/antagonists	09-6-19
07216	Catecholamine transferase inhibitors	09-6-19
07217	Angiotensin antagonists	09-6-19
07218	HIV protease inhibitors	09-11-13
07219	Cyclooxygenase inhibitors	09-11-12
07220	Cholinergic and anticholinergic drugs	09-10-10
07221	Nicotinic cholinergic receptor antagonists	09-6-19
07222	Peroxisome proliferator-activated receptor (PPAR) agonists	09-11-24
07223	Retinoic acid receptor (RAR) and retinoid X receptor (RXR) agonists/antagonists	09-12-29

Last updated: March 11, 2010
Back to KEGG table of contents